Cancer - A bull's eye for targeted lung cancer therapy

被引：59

作者：

Minna, JD ^{[1
]}

Gazdar, AF

Sprang, SR

Herz, J

机构：

[1] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA

[2] Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA

[3] Univ Texas, SW Med Ctr, Dept Pathol, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA

[4] Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dept Biochem, Dallas, TX 75390 USA

[5] Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA

来源：

SCIENCE | 2004年 / 304卷 / 5676期

关键词：

D O I：

10.1126/science.1099578

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

[No abstract available]

引用

页码：1458 / +

页数：3

共 6 条

[1] The role of EGFR inhibitors in nonsmall cell lung cancer [J].

Ciardiello, F ;

De Vita, F ;

Orditura, M ;

Tortora, G .

CURRENT OPINION IN ONCOLOGY, 2004, 16 (02) :130-135

[2] ST1571 (Gleevec™) as a paradigm for cancer therapy [J].

Druker, BJ .

TRENDS IN MOLECULAR MEDICINE, 2002, 8 (04) :S14-S18

[3]

Frederick L, 2000, CANCER RES, V60, P1383

[4] Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib [J].

Lynch, TJ ;

Bell, DW ;

Sordella, R ;

Gurubhagavatula, S ;

Okimoto, RA ;

Brannigan, BW ;

Harris, PL ;

Haserlat, SM ;

Supko, JG ;

Haluska, FG ;

Louis, DN ;

Christiani, DC ;

Settleman, J ;

Haber, DA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2129-2139

[5] EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy [J].

Paez, JG ;

Jänne, PA ;

Lee, JC ;

Tracy, S ;

Greulich, H ;

Gabriel, S ;

Herman, P ;

Kaye, FJ ;

Lindeman, N ;

Boggon, TJ ;

Naoki, K ;

Sasaki, H ;

Fujii, Y ;

Eck, MJ ;

Sellers, WR ;

Johnson, BE ;

Meyerson, M .

SCIENCE, 2004, 304 (5676) :1497-1500

[6] Lung cancer in US women - A contemporary epidemic [J].

Patel, JD ;

Bach, PB ;

Kris, MG .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (14) :1763-1768

← 1 →